ArticlePloS one2020

Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease.

Sheriza N Baksh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.